Company Update ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Alembic Pharmaceuticals receives USFDA Final Approval for Divalproex Sodium Delayed - Release Capsules USP, 125 mg